Indivior PLC (2IVB)

Currency in EUR
14.1000
+0.2000(+1.44%)
Closed·
Trading near 52-week High
Fair Value
Day's Range
13.800014.2000
52 wk Range
6.650014.2000
Key Statistics
Bid/Ask
14.40 / 14.50
Prev. Close
13.9
Open
13.9
Day's Range
13.8-14.2
52 wk Range
6.65-14.2
Volume
443
Average Volume (3m)
775
1-Year Change
42.41%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2IVB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Indivior PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Indivior PLC Company Profile

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Compare 2IVB to Peers and Sector

Metrics to compare
2IVB
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x0.0x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x0.0x
Price / LTM Sales
0.0x0.0x0.0x
Upside (Analyst Target)
0.0%0.0%0.0%
Fair Value Upside
Unlock0.0%0.0%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

2IVB Income Statement

People Also Watch

1,044.00
BAB
-0.57%
505.50
QQ
-0.20%
89.78
JD
+4.64%
499.50
NWG
-0.18%
300.40
SBRY
-0.33%

FAQ

What Stock Exchange Does Indivior PLC Trade On?

Indivior PLC is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Indivior PLC?

The stock symbol for Indivior PLC is "2IVB."

What Is the Indivior PLC Market Cap?

As of today, Indivior PLC market cap is 1.77B.

What Is Indivior PLC's Earnings Per Share (TTM)?

The Indivior PLC EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 2IVB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Indivior PLC Stock Split?

Indivior PLC has split 0 times.

What is the current trading status of Indivior PLC (2IVB)?

As of 23 Jul 2025, Indivior PLC (2IVB) is trading at a price of 14.10, with a previous close of 13.90. The stock has fluctuated within a day range of 13.80 to 14.20, while its 52-week range spans from 6.65 to 14.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.